Registration Dossier

Toxicological information

Neurotoxicity

Currently viewing:

Administrative data

Description of key information

The weight-of-evidence from acute toxicity studies conducted with 2,3-epoxypropyl neodecanoate demonstrated no adverse clinical signs of neurotoxicity.  

Key value for chemical safety assessment

Additional information

No clinical signs of neurotoxicity were observed in oral, dermal and inhalation acute toxicity studies conducted with 2,3 -epoxypropyl neodecanoate. Evidence of neurotoxicity was not observed in a five-week rat oral study.

Justification for classification or non-classification

There is insufficient study data upon which to base a decision for Classification.